James H. Simmons III
CIK: 0001825185
Associated companies
Transaction History
| REG | ▲ Buy | Option Exercise | 1,736 | — | 5/11/2026 | View on chart |
| REG | ▲ Buy | Option Exercise | 71 | — | 5/11/2026 | View on chart |
| REG | ▲ Buy | Option Exercise | 85 | — | 5/5/2025 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,115 | — | 5/5/2025 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,096 | — | 5/3/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 67 | — | 5/3/2024 | View on chart |
| REG | ▲ Buy | Option Exercise | 79 | — | 5/3/2023 | View on chart |
| REG | ▲ Buy | Option Exercise | 1,817 | — | 5/3/2023 | View on chart |
| REG | ▲ Buy | Option Exercise | 71 | — | 6/1/2022 | View on chart |
| REG | ▲ Buy | Option Exercise | 2,000 | — | 6/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Regency Centers Faces Analyst Adjustments Amid Rate Concerns
Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.
Regency Centers Faces Analyst Adjustments Amid Rate Concerns. Regency Centers is navigating a challenging environment as broader REITs face pressure from high interest rates. Recent analyst actions include Truist assuming coverage at a Buy rating and Barclays lowering its price target to $85 while maintaining an Overweight stance. The company is also preparing for its third-quarter 2026 earnings call, with the stock currently trading near its 52-week low.